Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review

S Łukasiewicz, M Czeczelewski, A Forma, J Baj… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer is the most common cancer among women. It is estimated
that 2.3 million new cases of BC are diagnosed globally each year. Based on mRNA gene …

Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: a comprehensive review

A Ismail, HA El-Mahdy, AI Abulsoud… - International Journal of …, 2023 - Elsevier
Breast cancer (BC) is the most common cancer in women and poses a serious threat to their
health. Despite familiarity with factors affecting its etiology, initiation, progression, treatment …

Prognostic and predictive biomarkers in breast cancer: Past, present and future

A Nicolini, P Ferrari, MJ Duffy - Seminars in cancer biology, 2018 - Elsevier
Following a diagnosis of breast cancer, the most immediate challenges in patient
management are the determination of prognosis and identification of the most appropriate …

[HTML][HTML] MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer

G Bertoli, C Cava, I Castiglioni - Theranostics, 2015 - ncbi.nlm.nih.gov
Dysregulation of microRNAs (miRNAs) is involved in the initiation and progression of
several human cancers, including breast cancer (BC), as strong evidence has been found …

Oxidative stress and cancer: an overview

V Sosa, T Moliné, R Somoza, R Paciucci… - Ageing research …, 2013 - Elsevier
Reactive species, which mainly include reactive oxygen species (ROS), are products
generated as a consequence of metabolic reactions in the mitochondria of eukaryotic cells …

MicroRNAs and cancer: Key paradigms in molecular therapy

W Tan, B Liu, S Qu, G Liang, W Luo… - Oncology …, 2018 - spandidos-publications.com
MicroRNAs (miRNAs) are a type of small non-coding RNA molecule that performs an
important role in post‑transcriptional gene regulation. Since miRNAs were first identified in …

microRNAs in cancer management

YW Kong, D Ferland-McCollough, TJ Jackson… - The lancet …, 2012 - thelancet.com
Since the identification of microRNAs (miRNAs) in 1993, and the subsequent discovery of
their highly conserved nature in 2000, the amount of research into their function …

MiRNA-210: a current overview

A Bavelloni, G Ramazzotti, A Poli, M Piazzi… - Anticancer …, 2017 - ar.iiarjournals.org
microRNAs (miRNAs) are a group of highly conserved small non-coding RNAs that were
found to enhance mRNA degradation or inhibit post-transcriptional translation. Accumulating …

MicroRNAs as potential biomarkers in cancer: opportunities and challenges

H Lan, H Lu, X Wang, H Jin - BioMed research international, 2015 - Wiley Online Library
MicroRNAs (miRNAs) are a group of small noncoding RNAs (ncRNAs) that
posttranscriptionally regulate gene expression by targeting their corresponding messenger …

Hypoxia-inducible factor 1 and breast cancer metastasis

Z Liu, GL Semenza, H Zhang - Journal of Zhejiang University-SCIENCE B, 2015 - Springer
Accumulating evidence has shown that the hypoxic microenvironment, which is critical
during cancer development, plays a key role in regulating breast cancer progression and …